REQUEST A DEMO
Total
USD $0.00
Search more companies

Salvisdiab CIA Ltda (Ecuador)

Main Activities: Optical Instrument and Lens Manufacturing
Full name: Salvisdiab CIA Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Salvisdiab CIA Ltda is based in Ecuador. The head office is in Quito. It operates in the Optical Instrument and Lens Manufacturing industry. The enterprise was incorporated on August 24, 2012. There are currently 4 (2021) people employed by Salvisdiab CIA Ltda. In its most recent financial highlights, the company reported a net sales revenue drop of 27.05% in 2022. There was a total negative growth of 79.64% in Salvisdiab CIA Ltda’s total assets over the same period. The enterprise’s net profit margin increased by 0.51% in 2022.

Headquarters
Vozandes 128, Livenza Bldg.
Quito; Pichincha;

Contact Details: Purchase the Salvisdiab CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Salvisdiab CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Salvisdiab CIA Ltda report to view the information.
Registered Capital:
Purchase the Salvisdiab CIA Ltda report to view the information.
Incorporation Date:
August 24, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
37.5%
Purchase this report to view the information.
37.5%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Salvisdiab CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-27.05%
Total operating revenue
-27.05%
Operating profit (EBIT)
-80.71%
Net Profit (Loss) for the Period
-12.09%
Total assets
-79.64%
Total equity
19.11%
Operating Profit Margin (ROS)
-8.19%
Net Profit Margin
0.51%
Return on Equity (ROE)
-1.89%
Quick Ratio
0.23%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?